The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clonal hematopoiesis in the phase 3 Alliance A031201 trial of metastatic castration resistant prostate cancer (mCRPC) treated with androgen receptor (AR)-targeted therapies.
 
Jeffrey Lee Jensen
Stock and Other Ownership Interests - Abbvie; Pfizer
 
Olivia Bobek
Employment - Epic (I)
Stock and Other Ownership Interests - Inovio Pharmaceuticals (I); Johnson & Johnson/Janssen (I); Merck (I); Pfizer (I); Procter & Gamble (I)
 
Irenaeus Chi-Chung Chan
No Relationships to Disclose
 
David W. Hillman
No Relationships to Disclose
 
Glenn Heller
No Relationships to Disclose
 
Todd E. Druley
Employment - Mission Bio
Leadership - Mission Bio
Consulting or Advisory Role - RhoDx
 
Michael J. Morris
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Amgen; AstraZeneca; Clarity Pharmaceuticals; Convergent Therapeutics; Daiichi; Exelixis; ITM Isotope Technologies Munich; Lantheus Medical Imaging; NCCN; Pfizer
Research Funding - Bayer (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Janssen (Inst); Novartis (Inst); Progenics (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - Bayer; Janssen Oncology; Novartis
 
Matthew I. Milowsky
Stock and Other Ownership Interests - Gilead Sciences; Merck; Pfizer
Consulting or Advisory Role - Loxo/Lilly
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Alliance Foundation Trials (Inst); ALX Oncology (Inst); Arvinas (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); G1 Therapeutics (Inst); Hoosier Cancer Research Network (Inst); Incyte (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Other Relationship - Elsevier; Medscape
 
Himisha Beltran
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Blue Earth Diagnostics; Curie Therapeutics; Daicchi Sankyo; Foundation Medicine; Janssen Oncology; Loxo/Lilly; Merck; Novartis; Pfizer; Sanofi
Research Funding - Abbvie/Stemcentrx (Inst); Bristol Myers Squibb Foundation (Inst); Daiichi Sankyo (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
KELLY L. BOLTON
Honoraria - Mission Bio
Consulting or Advisory Role - GoodCell
Research Funding - Bristol Myers Squibb Foundation; SERVIER
 
Catherine Callaghan Coombs
Stock and Other Ownership Interests - Bluebird Bio; CTI BioPharma Corp
Honoraria - Abbvie; AstraZeneca; BeiGene; Genentech; H3 Biomedicine; Janssen; LOXO; MEI Pharma; MingSight; Novartis; Octapharm; Pharmacyclics; TG Therapeutics
Consulting or Advisory Role - Abbvie; Genentech; Lilly
Speakers' Bureau - Abbvie; BeiGene; Genentech
Research Funding - Loxo (Inst)